Maximilian Klimpel, Monica Terrao, Melina Bräuer, Herbert Dersch, Martina Biserni, Larissa Melo Do Nascimento, Sarah Schwingal, Jessica E Vogel, Cathrin Ferlemann, Tobias Brandt, Nikki Indresh Lal, Krystal Bridgeman, Alex Petzke, Eva McDwyer, Jo Leen Lim, Seungyoul Oh, Gabriela Brumatti, Albert Garcia Minambres, Ellen Otte, Thomas Noll, Vicky Pirzas, Holger Laux
The production of lentiviral vectors (LVs) pseudotyped with the vesicular stomatitis virus envelope glycoprotein (VSV-G) is limited by the associated cytotoxicity of the envelope and by the production methods used, such as transient transfection of adherent cell lines. In this study, we established stable suspension producer cell lines for scalable and serum-free LV production derived from two stable, inducible packaging cell lines, named GPRG and GPRTG. The established polyclonal producer cell lines produce self-inactivating (SIN) LVs carrying a WAS-T2A-GFP construct at an average infectious titer of up to 4...
May 2024: Biotechnology Journal